At lunch on Monday the S&P/ASX 200 Index (ASX: XJO) has fought back from an early decline and is storming higher. The benchmark index is currently up 0.5% to 5,955.9 points.
Here’s what is happening on the market today:
CSL signs COVID-19 vaccine agreements.
The CSL Limited (ASX: CSL) share price is pushing higher today after announcing two COVID-19 vaccine agreements. The biotherapeutics company signed an agreement with the Australian Government to supply 51 million doses of University of Queensland’s potential UQ-CSL V451 COVID-19 vaccine. It also signed an agreement with AstraZeneca for the expected manufacture of approximately 30 million doses of the Oxford University vaccine candidate AZD1222 for supply to Australia. These are both pending successful clinical trials.
Tech rout over?
After a couple of tough days, there are signs that the tech sector rout may be over. The S&P/ASX 200 Information Technology index tumbled 2.5% lower this morning but is now almost trading flat. The Afterpay Ltd (ASX: APT) share price is playing a key role in this recovery. It was down almost 5% in early trade but is now less than 1% lower. I suspect bargain hunters may be swooping in after some sizeable declines in the sector.
Big four bank shares higher.
One group of shares that have started the week strongly are the banks. All the big four banks are pushing notably higher today and are helping to drive the ASX 200 higher. The best performer in the group has been the Westpac Banking Corp (ASX: WBC) share price with a gain of almost 2.5%.
Best and worst ASX 200 performers.
The best performer on the ASX 200 on Monday has been the Virgin Money UK PLC (ASX: VUK) share price with a gain of 5%. This is despite there being no news out of the UK-based bank. The worst performer is the Mesoblast limited (ASX: MSB) share price with a 4% decline. This appears to be due to profit taking after some very strong gains in recent months.
Man who said buy Kogan shares at $3.63 says buy these 3 ASX stocks now
When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*
In this FREE STOCK REPORT, Scott just revealed what he believes are the 3 ASX stocks for the post COVID world that investors should buy right now while they still can. These stocks are trading at dirt-cheap prices and Scott thinks these could really go gangbusters as we move into ‘the new normal’.
Find out the names of our 3 Post COVID Stocks – For FREE!
*Returns as of 6/8/2020
More reading
- Afterpay, Zip founders team up for ‘Aussie Robinhood’ app
- Why the Ramelius share price is leading the gold sector higher today
- Why Afterpay, ASX, Mesoblast, & Sydney Airport shares are dropping lower
- 4 of the best ASX shares to buy before 2021
- CSL share price higher on COVID-19 vaccine news
James Mickleboro owns shares of Westpac Banking. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of CSL Ltd. The Motley Fool Australia owns shares of AFTERPAY T FPO. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.
The post ASX 200 up 0.5%: CSL signs COVID-19 vaccine agreements, big four banks charge higher appeared first on Motley Fool Australia.
from Motley Fool Australia https://ift.tt/2F9CxdZ
Leave a Reply